A randomized, open-label, comparative study for Edoxaban and Enoxaparin/Warfarin vs Warfarin alone in subjects with Atrial Fibrillation who have undergone Electrical Cardioversion
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: Atrial Fibrillation | ablation | electrical cardioversion | atrial fibrillation
Age: Between 1 - 99 Years
Gender: Male or Female
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required